To the Editor,
The diagnosis and treatment of diarrhea can be challenging. Diabetic diarrhea is seen mainly in patients with poorly controlled insulin-dependent diabetes who also have symptoms of diabetic peripheral and autonomic neuropathy. Typically, the diarrhea is painless, occurs during the day and night, and may be associated with fecal incontinence [1] . We used ramosetron, a selective 5-HT 3 receptor antagonist, to treat diabetic diarrhea with a rapid small bowel transit time.
A 49-year-old man who had developed type 2 diabetes mellitus at 42 years of age, presented with diarrhea 6 months ago. His glycemia was poorly controlled, based on a haemoglobin A1c of 17.7%. He had hypercholesterolemia, orthostatic hypotension, diabetic retinopathy, nephropathy, peripheral neuropathy, autonomic neuropathy, and gastroparesis. Current medications included insulin, losartan, atorvastatin, midodrine, metoclopramide, and domperidone. Diarrhea occurred at a frequency of > 10 bowel movements per day, with fecal urgency following meals. Steatorrhea was absent and the stool examination was unremarkable. He was prescribed conventional antidiarrheals, including a pancreatic enzyme supplement, rifaximin, probiotics, cimetropium bromide, and loperamide, but these were ineffective. He also had iron-deficiency anemia, as evidenced by a hemoglobin of 9.1 g/dL, mean corpuscular volume of 84.7 f L, 1.95% reticulocytes, and ferritin of 8.45 ng/ mL. Capsule endoscopy (PillCam SB2, Given Imaging, Yokneam, Israel) was performed after upper endoscopy, colonoscopy, and abdominal computed tomography failed to explain the iron-deficiency anemia. He fasted for 12 hours before capsule ingestion. For 4 hours following ingestion of the capsule, only water was permitted, after which a liquid diet was offered. All medications except the losartan were discontinued. Capsule endoscopy identif ied multiple angiodysplastic lesions in the distal ileum. Interestingly, a markedly prolonged gastric emptying time (13 hours 33 minutes) with a rapid small bowel transit time (14 minutes) was noted (Fig. 1) , suggesting gastroparesis and autonomic neuropathy, respectively. The diarrhea persisted, so ramosetron therapy (Irribow, Astellas Pharma Korea, Seoul, Korea) was started at 5 μg once daily before breakfast. The diarrhea and fecal urgency disappeared completely after 1 week of ramosetron treatment, with the bowel movement frequency reduced to two soft stools per day. On ceasing ramosetron, the diarrhea re-www.kjim.org Lee TH and Lee JS. Ramosetron for diabetic diarrhea curred, but was relieved once more when the medication was restarted. 5-Hydroxytrytamine (5-HT) acts on 5-HT 3 parasympathetic receptors to produce smooth muscle contraction and the release of acetylcholine from nerve terminals, causing intestinal secretion to increase [2] . The 5-HT 3 receptor antagonist alosetron is useful in the treatment of diarrhea in patients with irritable bowel syndrome, but must be avoided in more severe cases because of the risk of constipation [3] . The efficacy of other 5-HT 3 receptor antagonists such as ondansetron [4] and ramosetron [5] in the treatment of diabetic diarrhea has been documented.
In conclusion, given the inhibitory effects of a 5-HT 3 receptor antagonist on smooth muscle contraction and secretion, ramosetron should be considered in cases of diabetic diarrhea with rapid small bowel transit. A larger study is needed to verify the efficacy of ramosetron in treating this condition.
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